An open-label study of the effect of first-line treatment with Avastin [bevacizumab] combined with irinotecan and 5-fluorouracil on survival in patients with metastatic colorectal cancer
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Bevacizumab; Fluorouracil; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Mar 2008 Status changed from in progress to completed.
- 08 Jun 2006 New trial record.